Live Blog

Sensex gains 180 pts, broader indices outperform; Glenmark Pharma soars 27%

All that happened in the markets today

SI Reporter New Delhi
markets
Cipla hit a fresh 52-week high of Rs 696 on the BSE

3 min read Last Updated : Jun 22 2020 | 4:28 PM IST

4:19 PM

MARKET COMMENT:: Vinod Nair, Head of Research at Geojit Financial Services

"In spite of renewed global concerns regarding the second wave of coronavirus infections, Indian markets ended on a positive note. Markets chose to focus on regulatory approvals to domestic pharma companies to manufacture covid-19 treatment drugs and the expectation that this would lead to faster recoveries. As such, the pharma index was the major sectoral gainer in today’s trade. Concerns remain with regard to the increasing infections and the ongoing situation with China, and investors are advised to keep a short term outlook for the time being."

3:45 PM

SECTOR WATCH:: Nifty IT ends in the red

3:42 PM

MARKET AT CLOSE:: Gainers and losers on the S&P BSE Sensex

3:37 PM

CLOSING BELL

The S&P BSE Sensex rallied 180 points or 0.5 per cent to end at 34,911 while NSE's Nifty ended at 10,311, down 67 points or 0.65 per cent.

3:23 PM

INDEX LOSER:: HDFC down 1%

3:18 PM

BUZZING STOCK:: PTC India zooms 15%

3:10 PM

RBI bars YES Bank from coupon payment on Upper Tier II bonds

The private lender had approached banking sector regulator RBI seeking approval to pay interest due as on June 29, 2020 for Upper Tier II Bonds. These Unsecured Non-Convertible Upper Tier II bonds carry coupon of 10.25 per cent.
 
Its overall capital adequacy ratio stood at 8.5 per cent at end of March 2020 with Common Equity tier I (CET I) of 6.3 per cent. Its stock was trading 1.8 per cent lower on BSE. The capital adequacy ratio is below the regulatory requirements. READ MORE

3:09 PM

MARKET UPDATE: Sharp fall in Sensex from day's high

2:59 PM

Top contributors to today's up move in Sensex

2:54 PM

Stocks that hit 52-week high on BSE today

COMPANY PRICE(rs) 52 WK HIGH CHG(%)
ADANI GREEN 441.60 441.60 4.99
ALEMBIC PHARMA 952.00 984.00 0.64
BAYER CROP SCI. 5890.00 6091.00 -1.70
CIPLA 660.50 696.00 3.67
DIXON TECHNOLOG. 5586.90 5819.10 -1.77
» More on 52 Week High

2:50 PM

Bank of Baroda Q4 preview: Covid-19, telecom stress may keep earnings muted

Hit by business disruption amid Covid-19 outbreak and merger with Dena and Vijaya Bank, state-owned Bank of Baroda is likely to post muted March quarterly earnings on Tuesday, June 23. While analysts remain divided on the bank’s net profit, which ranges from Rs 356 crore to (-) Rs 1,659 crore; asset quality figures due to exposure to the telecom sector would be under their radar. READ MORE

2:41 PM

Top gainers on BSE today

COMPANY PRICE(rs) CHG(%)
GLENMARK PHARMA. 534.45 30.64
INDIABULLS HOUS. 250.85 22.88
PTC INDIA 47.15 15.42
IRB INFRA.DEVL. 81.10 14.71
INDIAN BANK 64.30 14.31
» More on Top Gainers

2:29 PM

BROKERAGE VIEW:: ICICI Securities on Shalby Ltd

Like other hospitals, Q4 performance was impacted by Covid 19. This is likely to continue for some time and more so for Shalby where significant traction is from elective surgeries (read arthroplasty) although management remains hopeful of early recovery. Arthroplasty continues to dominate its revenue pie although it has been seeing greater traction in other specialities as well. Leverage free b/s, strong margins and free cash flow generation are some of the strongholds. However, skewed margins, weak return ratios are still major concerns. We value the company on an SOTP basis by valuing hospitals (above six years) at 6x FY22E EV/EBITDA and hospitals (below six years) at 1x FY22E EV/sales. We arrive at an SOTP target price of Rs 70. Ramp up in below six years hospitals will be key to watch for re-rating.

2:22 PM

BUZZING STOCK:: IDFC First Bank soars 10%

2:11 PM

MARKET UPDATE:: IRB Infra jumps 15%

Topics :CoronavirusMarketsDalmia BharatReliance Industries LtdRamco SystemsYES BankMARKET WRAP

First Published: Jun 22 2020 | 7:37 AM IST